Biotechnology

GenScript Biotech Corporation signs exclusive agreement with PH biotech firm to distribute faster, more accurate and more affordable immunity tests for COVID-19

SINGAPORE, Sept. 1, 2020 /PRNewswire/ -- GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK) entered an exclusive partnership with Philippines biotech company, IP Biotech. ). This will allow the firm to distribute a breakthrough test kit designed to measure the levels of neutralizing...

2020-09-01 10:30 10540

Cedrus Group's Chairman Mr. Rani Jarkas Invited to Speak at the ANNUAL BIOPHARMA DEVELOPMENT AND PRODUCTION WEEK

HONG KONG, Sept. 1, 2020 /PRNewswire/ -- The Chairman of Cedrus Group ("Cedrus") , Mr. Rani Jarkas, is invited to speak at the"6th Annual Biopharma Development and Production Week" conference to be held on 3rd - 5th November 2020. This year, the event will be ...

2020-09-01 09:00 4969

Origin Agritech to Present at The LD 500 Virtual Conference

BEIJING,, Aug. 31, 2020 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED)  (the "Company" or "Origin"), an agriculture technology company, today announced that it will be presenting at the LD 500 investor conference on Friday, September 4th at8 AM PST / 11 AM EST. Origin's Chairman and Chief Ex...

2020-09-01 01:41 16892

Viva Biotech Announced 2020 Interim Results

Financial Highlights for the 6 months ended June 30, 2020 * Revenue amounted to RMB197.6 million, representing a YOY increase of 38.9% * Gross profit amounted to RMB100.1 million, representing a YOY increase of 39.2%, with Gross profit margin of 50.7% * Adjusted net profit rose to RMB123.7 m...

2020-08-31 23:27 7266

Transcenta Announces First Patient Dosed in Phase I China Trial of Claudin18.2 Targeting Monoclonal Antibody TST001

SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, development and manufacturing of antibody-based therapeutics, announced today that the first subject has been dosed successful...

2020-08-31 23:00 2029

GenScript Reports 2020 Interim Results and Provides Business Update

NANJING, China, Aug. 31, 2020 /PRNewswire/ -- GenScript Biotech Corp. (Stock Code: 1548.HK), a leading global biotechnology company, today reported interim results for the six months endedJune 30, 2020 and provided a corporate update. Revenue of the Group for the six months endedJune 30, 2020 was...

2020-08-31 11:32 11861

Shandong stages welcoming event for Europe's Fortune 500 companies

JINAN, China, Aug. 30, 2020 /PRNewswire/ -- The "Connecting Shandong with Fortune Global 500" series of events, hosted by the CPC Shandong Provincial Committee and Shandong Provincial People's Government, organized by the Department of Commerce ofShandong Province, and sponsored by FORTUNE CHINA,...

2020-08-31 10:42 2496

Innovent Announces the Results of the Phase 1/2 Clinical Study of PCSK9 Antibody Tafolecimab at the European Society of Cardiology Annual Conference

SAN FRANCISCO and SUZHOU, China, Aug. 31, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune a...

2020-08-31 08:00 5805

G-ray Switzerland announces new CEO, closes successful funding round

NEUCHÂTEL, Switzerland, Aug. 31, 2020 /PRNewswire/ -- G-ray Switzerland, the medical imaging and industrial diagnosis start-up founded in 2014, has announced the appointment of Luis Pallares as Chief Executive Officer, as the company embarks on an accelerated growth drive and completes a successf...

2020-08-31 06:00 3887

Million-selling Erba COVID-19 antibody tests now validated on leading ELISA analysers

LONDON, Aug. 31, 2020 /PRNewswire/ -- To improve global availability of high-quality testing methods for SARS-CoV-2,Erba Mannheim announced the availability of validated automated protocols for their successful range of ErbaLisa COVID-19 IgG and IgM ELISA kits. Optimised protocols for popular ins...

2020-08-31 06:00 3358

Changsha Haike, a HYCOR Biomedical Partner, Announces Registration From China HMPA for the ALLEOS™ 2000 System

GARDEN GROVE, California, Aug. 29, 2020 /PRNewswire/ -- HYCOR Biomedical, a leading manufacturer ofin vitro diagnostic products for allergy testing, and Changsha Haike Biotechnology Co., Ltd., its Chinese manufacturing partner, announced registration from Hunan Medical Products Administration ...

2020-08-29 05:03 6431

New finding - Patient Blood Management delivers cost-effective care

BASEL, Switzerland, Aug. 28, 2020 /PRNewswire/ -- Research recently published in the journal Anaesthesia , looked at the economic case for screening and treating anaemia and iron deficiency prior to elective surgery. The five-year stud...

2020-08-28 16:31 1369

Sirtex Medical and China Grand Pharmaceutical announce landmark drug registration milestone

Approval issued to file new drug application for SIR-Spheres® Y-90 resin microspheres inChina based on existing clinical trial data. WOBURN, Mass., Aug. 27, 2020 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today that Sirtex and ...

2020-08-27 20:30 3719

Enrolment initiated in World's First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

SINGAPORE, Aug. 27, 2020 /PRNewswire/ -- Concept Medical Inc ., focused on vascular intervention drug delivery devices, has announced the enrolment of the first patient in theFUTURE BTK trial (Randomized Controlled Trial of First SirolimUs CoaTed Balloon VersUs S...

2020-08-27 18:16 4207

Ascentage Pharma Releases Preclinical Results of IAP Antagonist APG-1387 in an Oral Presentation at EASL ILC 2020

SUZHOU, China and ROCKVILLE, Md., Aug. 27, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that preclinical study resul...

2020-08-27 18:10 5024

How the Dutch resume elective surgery in melanoma after COVID delays

ROTTERDAM, Netherlands and SAN DIEGO, Aug. 26, 2020 /PRNewswire/ -- SkylineDx signed a collaboration agreement with a multi-disciplinary clinical consortium inthe Netherlands that designed a trial to implement a diagnostic innovation to manage continuity of care delivery when resources are under ...

2020-08-26 21:06 3025

GoBroad Healthcare Group Showcases Innovative Hematologic Treatment Capabilities at the China Precision Medicine Forum

BEIJING, Aug. 26, 2020 /PRNewswire/ -- GoBroad Healthcare Group hosted the China Precision Medicine Forum in Hematologic Malignancies & 2nd GoBroad Annual Medical Conference (diagnosis and treatment of diseases of the blood and bone marrow) in early August, covering subjects including diagnosis, ...

2020-08-26 21:00 2113

DiscGenics Raises $50 Million in Series C Funding

SALT LAKE CITY, Aug. 26, 2020 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biopharmaceutical company developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced it has raised$50 million in a Serie...

2020-08-26 08:30 3267

RoboPharma Acquired by Capsa Healthcare to Broaden Reach Into New Pharmacy Automation Markets

WAALWIJK, Netherlands, Aug. 26, 2020 /PRNewswire/ -- RoboPharma announced today the company has been acquired by Capsa Healthcare, a worldwide innovator in healthcare delivery solutions for hospitals, senior care settings, and retail pharmacy providers. Becoming an integral segment within Capsa H...

2020-08-26 08:12 2491

AGC Biologics Completes PPQ Manufacturing Campaign with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab

SEATTLE, Aug. 25, 2020 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), achieved the on-schedule completion of a drug substance Process Performance Qualification (PPQ) campaign, focused on teplizumab  (PRV-031) for partn...

2020-08-25 22:00 5743
1 ... 278279280281282283284 ... 306